BioCentury
ARTICLE | Clinical News

Sepracor Phase III Estorra results

May 21, 2003 7:00 AM UTC

SEPR said in a double-blind, placebo-controlled, six-month Phase III trial in 792 chronic insomnia patients, its Estorra significantly improved sleep maintenance measures (p<0.01). These measures incl...